Anti-Human CD85a/LILRB3 Antibody (A1), PE

Catalog No.

FHB05912

Species reactivity

Human

Host species

Human

Isotype

IgG1, lambda

Clonality

Monoclonal

Conjugation

PE

Target

CD85a, ILT-5, Monocyte inhibitory receptor HL9, LILRB3, Immunoglobulin-like transcript 5, CD85 antigen-like family member A, ILT5, Leukocyte immunoglobulin-like receptor 3, LIR-3, Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR3

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

O75022

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

A1

Comparison of the Mutational Profile between BCL2- and BCL6-Rearrangement Positive Follicular Lymphoma., PMID:40482882

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement., PMID:38462571

Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma., PMID:36975733

Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels., PMID:36358737

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation., PMID:32870822

Document Download

Anti-Human CD85a/LILRB3 Antibody (A1), PE.pdf